Norwich, NY, United States of America

Stanford S Pelosi, Jr


Average Co-Inventor Count = 1.3

ph-index = 4

Forward Citations = 93(Granted Patents)

Forward Citations (Not Self Cited) = 67(Dec 10, 2025)


Inventors with similar research interests:


Company Filing History:


Years Active: 1976-2000

Loading Chart...
Areas of Expertise:
Cyclic Ureas
Antiarrhythmic Agents
Antifibrillatory Agents
5-Phenyl-2-Furan Ketones
Antiepileptic Agents
Cardiotonic Agents
Furancarboximidamides
Thiocyanatobenzothiazoles
Imidazoles
Hydrazides
Benzothiazines
Phenyl Ketones
51 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Stanford S. Pelosi, Jr.

Introduction: Stanford S. Pelosi, Jr. is a highly accomplished inventor based in Norwich, NY, known for his significant contributions to the field of pharmaceuticals. With an impressive portfolio that includes 51 patents, his work has focused on developing novel compounds aimed at treating cardiac conditions.

Latest Patents: Among his latest innovations are the patents for cyclic ureas and cyclic urethanes, both of which serve as antiarrhythmic and antifibrillatory agents. The cyclic urea-containing compounds showcase a specific structure, where X and Y represent a variety of cyclic moieties. This innovation offers potential therapeutic benefits for individuals suffering from cardiac arrhythmias and fibrillation. Similarly, Stanford's cyclic urethanes come with general structures that also provide treatment possibilities for such cardiac issues through their pharmaceutically acceptable salts and esters.

Career Highlights: Throughout his career, Stanford has made substantial strides in pharmaceutical development. He has been associated with several notable companies, including Morton-Norwich Products, Inc. and Norwich Eaton Pharmaceuticals, Inc. His dedication to research and innovation has positioned him as a vital contributor within the pharmaceutical sector.

Collaborations: Collaborating with esteemed colleagues such as Chia-Nien Yu and Ronald E. White, Stanford has combined his expertise and knowledge to drive forward significant advancements in the development of cardiac therapeutics.

Conclusion: With 51 patents to his name, Stanford S. Pelosi, Jr. continues to be a pivotal figure in pharmaceutical innovation. His dedication to creating effective treatment options for heart conditions highlights his commitment to improving patient outcomes and advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…